Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

ClinicalTrials.gov ID: NCT06848348

Public ClinicalTrials.gov record NCT06848348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled, Multicenter Study With Optional Open-Label Extension to Evaluate the Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extension phase, where available, in which all subjects will receive Halneuron.

Study identification

NCT ID
NCT06848348
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dogwood Therapeutics Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2025 (Actual)
Primary completion
Dec 2026 (Estimated)
Completion
Dec 2026 (Estimated)
Last update posted
Sep 16, 2026

2025 – 2026

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Central Recruiting Site Sheffield Alabama 35660 —
Central Recruiting Site Glendale Arizona 85308 —
Central Recruiting Site Phoenix Arizona 85022 —
Central Recruiting Site Fair Oaks California 95628 —
Central Recruiting Site Fountain Valley California 92708 —
Central Recruiting Site Los Angeles California 91307 —
Central Recruiting Site Santa Rosa California 95403 —
Central Recruiting Site Wheat Ridge Colorado 80033 —
Central Recruiting Site Jacksonville Florida 32205 —
Central Recruiting Site Jacksonville Florida 32256 —
Central Recruiting Site Lakeland Florida 33812 —
Central Recruiting Site Orlando Florida 32832 —
Central Recruiting Site Port Charlotte Florida 33952 —
Central Recruiting Site Tampa Florida 33613 —
Central Recruiting Site Gurnee Illinois 60031 —
Central Recruiting Site Lake Charles Louisiana 70605 —
Central Recruiting Site Fenton Missouri 63026 —
Central Recruiting Site Las Vegas Nevada 89109 —
Central Recruiting Site Garden City New York 11530 —
Central Recruiting Site Williamsville New York 14221 —
Central Recruiting Site Winston-Salem North Carolina 27103 —
Central Recruiting Site Houston Texas 77346 —
Central Recruiting Site McAllen Texas 78504 —
Central Recruiting Site Salt Lake City Utah 84107 —
Central Recruiting Site Madison Wisconsin 53715 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06848348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06848348 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →